Jason Cameron

Associate Director Bristol Myers Squibb

Jason Cameron is an access programme leader at Bristol Myers Squibb, focused on designing and delivering global Early and Expanded Access programmes that enable patients to receive innovative therapies ahead of approval. He brings strong expertise in operationalising access strategies, from programme design and process optimisation to system implementation and cross-functional execution across complex organisations. Jason has led global access mechanism initiatives across Europe and beyond, working closely with medical, regulatory, and commercial teams to build scalable, patient-centred access solutions that deliver impact in real-world settings.

Seminars

Monday 19th October 2026
Workshop B – Setting Up & Structuring Early Access Programmes That Remain Controllable Over Time
11:30 am
  • Designing early access programme structures that align with execution capacity, internal workflows, and real-world delivery constraints
  • Making deliberate set-up decisions around eligibility, geographic scope, governance, and duration that determine how manageable a programme becomes in practice
  • Understanding how early structural choices shape future options for scaling, transitioning, reimbursement engagement, or programme closure
Jason Cameron - 5th Operationalise Early Access Programmes Europe